Autres langues Yield10 Bioscience, Inc.

Actions

YTEN

US98585K8541

Marché Fermé - OTC Markets Autres places de cotation 20:12:31 16/07/2024			Varia. 5j.	Varia. 1 janv.
0,86 ^USD	+4,19 %		-1,73 %	-85,03 %

17/06	Rothamsted Research accorde à Yield10 Bioscience une licence commerciale mondiale exclusive sur une technologie avancée de production de produits oméga-3 à partir de la caméline	CI
15/05	Yield10 Bioscience, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina	17/06
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina	17/06
Yield10 Bioscience : Certificate of Incorporation/Bylaws Form 8 K	12/06
Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label	23/05
Yield10 Bioscience, Inc.(OTCPK:YTEN) dropped from S&P TMI Index	20/05
Earnings Flash (YTEN) YIELD10 BIOSCIENCE Posts Q1 Revenue $300,000	15/05
Yield10 Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Yield10 Bioscience Announces First Quarter 2024 Financial Results	15/05
Top Midday Decliners	15/05
Yield10 Bioscience to Delist From Nasdaq; Shares Drop	15/05
Yield10 Bioscience Announces Delisting from Nasdaq	15/05
Yield10 Bioscience, Inc.(OTCPK:YTEN) dropped from NASDAQ Composite Index	15/05
Yield10 Bioscience Announces 1-for-24 Reverse Stock Split	01/05
Yield10 Bioscience : 2024 Special Meeting of Stockholders	02/04
Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/04
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results	01/04
Yield10 Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024	28/03
Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada	26/03
Yield10 Bioscience, Inc. Announces the Plant Biosafety Office of the Canadian Food Inspection Agency Clear Genome-edited E3902 Camelina for Planting in Canada	26/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Yield10 Bioscience, Inc.

Actions

YTEN

US98585K8541

Autres langues

Filtres